Clinical Trials Browser

Endometrial Adenocarcinoma × brivanib × Genitourinary × Clear all

NCT00888173 2017-12-06

Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

45 enrolled 10 charts

GenitourinaryGynecologic

Endometrial Adenocarcinoma